| Basics |
iShares Nasdaq Biotechnology ETF
The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc.
The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
|
| IPO Date: |
February 9, 2001 |
| Sector: |
Biotech |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$1.13 | 0.98%
|
| Avg Daily Range (30 D): |
$1.12 | 0.86%
|
| Avg Daily Range (90 D): |
$1.50 | 1.22%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.91M |
| Avg Daily Volume (30 D): |
1.56M |
| Avg Daily Volume (90 D): |
1.74M |
| Trade Size |
| Avg Trade Size (Sh.): |
140 |
| Avg Trade Size (Sh.) (30 D): |
54 |
| Avg Trade Size (Sh.) (90 D): |
65 |
| Institutional Trades |
| Total Inst.Trades: |
28,111 |
| Avg Inst. Trade: |
$4.9M |
| Avg Inst. Trade (30 D): |
$5.05M |
| Avg Inst. Trade (90 D): |
$5.62M |
| Avg Inst. Trade Volume: |
.1M |
| Avg Inst. Trades (Per Day): |
5 |
| Market Closing Trades |
| Avg Closing Trade: |
$10.05M |
| Avg Closing Trade (30 D): |
$2.46M |
| Avg Closing Trade (90 D): |
$3.1M |
| Avg Closing Volume: |
111.64K |
|
|
|
|
|
